Literature DB >> 18024429

Regulation of alternative splicing: more than just the ABCs.

Amy E House1, Kristen W Lynch.   

Abstract

Alternative pre-mRNA splicing, the differential inclusion or exclusion of portions of a nascent transcript into the final protein-coding mRNA, is widely recognized to be a ubiquitous mechanism for controlling protein expression. Thus, understanding the molecular basis of alternative splicing is essential for deciphering post-transcriptional control of the genome. Pre-mRNA splicing in general is catalyzed by a large dynamic macromolecular machine known as the spliceosome. Notably, the recognition of the intron substrate by spliceosomal components and the assembly of these components to form a catalytic spliceosome occur through a network of highly combinatorial molecular interactions. Many, if not all, of these interactions are subject to regulation, forming the basis of alternative splicing. This minireview focuses on recent advances in our understanding of the diversity of mechanisms by which the spliceosome can be regulated so as to achieve precise control of alternative splicing under a range of cellular conditions.

Mesh:

Substances:

Year:  2007        PMID: 18024429     DOI: 10.1074/jbc.R700031200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  Intragenic alternative splicing coordination is essential for Caenorhabditis elegans slo-1 gene function.

Authors:  Dominique A Glauser; Brandon E Johnson; Richard W Aldrich; Miriam B Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

2.  RPL30 regulation of splicing reveals distinct roles for Cbp80 in U1 and U2 snRNP cotranscriptional recruitment.

Authors:  Mireia Bragulat; Markus Meyer; Sara Macías; Maria Camats; Mireia Labrador; Josep Vilardell
Journal:  RNA       Date:  2010-08-27       Impact factor: 4.942

Review 3.  Developments in RNA splicing and disease.

Authors:  Michael G Poulos; Ranjan Batra; Konstantinos Charizanis; Maurice S Swanson
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

4.  Alternative splicing as a therapeutic target for human diseases.

Authors:  Kenneth J Dery; Veronica Gusti; Shikha Gaur; John E Shively; Yun Yen; Rajesh K Gaur
Journal:  Methods Mol Biol       Date:  2009

Review 5.  The alternative heart: impact of alternative splicing in heart disease.

Authors:  Enrique Lara-Pezzi; Jesús Gómez-Salinero; Alberto Gatto; Pablo García-Pavía
Journal:  J Cardiovasc Transl Res       Date:  2013-06-18       Impact factor: 4.132

6.  BRCA1 exon 11 a model of long exon splicing regulation.

Authors:  Michela Raponi; Lindsay D Smith; Marco Silipo; Cristiana Stuani; Emanuele Buratti; Diana Baralle
Journal:  RNA Biol       Date:  2014-03-18       Impact factor: 4.652

7.  Repression of prespliceosome complex formation at two distinct steps by Fox-1/Fox-2 proteins.

Authors:  Hua-Lin Zhou; Hua Lou
Journal:  Mol Cell Biol       Date:  2008-06-23       Impact factor: 4.272

Review 8.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

9.  CUGBP2 directly interacts with U2 17S snRNP components and promotes U2 snRNA binding to cardiac troponin T pre-mRNA.

Authors:  Young-Hwa Goo; Thomas A Cooper
Journal:  Nucleic Acids Res       Date:  2009-05-14       Impact factor: 16.971

10.  A novel mannose-binding lectin/ficolin-associated protein is highly expressed in heart and skeletal muscle tissues and inhibits complement activation.

Authors:  Mikkel-Ole Skjoedt; Tina Hummelshoj; Yaseelan Palarasah; Christian Honore; Claus Koch; Karsten Skjodt; Peter Garred
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.